Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Techniques in Coloproctology
Metadata
Title
Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer
Authors
C. Emmanouilides
M. Pegram
R. Robinson
R. Hecht
F. Kabbinavar
W. Isacoff
Publication date
01-11-2004
Publisher
Springer-Verlag
Published in
Techniques in Coloproctology / Issue Special Issue 1/2004
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-004-0110-4

Other articles of this Special Issue 1/2004

Techniques in Coloproctology 1/2004 Go to the issue

OriginalPaper

Synchronous colorectal cancer

OriginalPaper

Colorectal gastrointestinal mesenchymal tumours. Report of a stromal case of the rectum (GIST) and a leiomyosarcoma of the transverse colon

OriginalPaper

Screening for colorectal cancer

OriginalPaper

Progress in the treatment of colorectal cancer

OriginalPaper

Anastomotic leakage following anterior resection for rectal cancer

OriginalPaper

Locally recurrent rectal cancer after curative resection